The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Herpesviruses: latency and reactivation – viral strategies and host response
Open accessAbstract
Eight members of the Herpesviridae family commonly infect humans, and close to 100% of the adult population is infected with at least one of these. The five that cause the most health concerns are: herpes simplex virus (HSV) type 1 and 2, Epstein-Barr virus (EBV), cytomegalovirus (CMV), and varicella zoster virus (VZV). In addition, there are human herpes virus (HHV) types 6-8. The review starts by introducing possible viral strategies in general. The particular biology and host relationship of the various human herpesviruses, including their pathology, are examined subsequently. Factors that contribute to the maintenance of latency and reactivation of viral replication are discussed. There will be special reference to how these viruses exploit and contribute to pathology in the oral cavity. Reactivation does not necessarily imply clinical symptoms, as reflected in the asymptomatic shedding of EBV and CMV from oral mucosa. The immune response and the level of viral output are both important to the consequences experienced.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1992) · Applied Ergonomics · doi:10.1016/0003-6870(92)90318-p · Cited by 5,737
Herpesvirus latency confers symbiotic protection from bacterial infection
Barton, E. S., White, D. W., Cathelyn, J. S., Brett-McClellan, K. A., Engle, M., Diamond, M. S., Miller, V. L., & Virgin, H. W. (2007) · Nature · doi:10.1038/nature05762 · Cited by 763
Viruses, microRNAs, and Host Interactions
Skalsky, R. L., & Cullen, B. R. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134243 · Cited by 676
Decoding Human Cytomegalovirus
Stern-Ginossar, N., Weisburd, B., Michalski, A., Le, V. T. K., Hein, M. Y., Huang, S.-X., Ma, M., Shen, B., Qian, S.-B., Hengel, H., et al. (2012) · Science · doi:10.1126/science.1227919 · Cited by 589 · cited 1×
“For example, in the case of cytomegalovirus (CMV), alternative splicing and optional start codons give rise to more than 700 different viral proteins (8).”
BackgroundHerpes Simplex Epithelial and Stromal Keratitis: An Epidemiologic Update
Farooq, A. V., & Shukla, D. (2012) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2012.01.005 · Cited by 479
A population-based study of primary human herpesvirus 6 infection
Zerr, D. M., Meier, A. S., Selke, S. S., Frenkel, L. M., Huang, M.-L., Wald, A., Rhoads, M. P., Nguy, L., Bornemann, R., Morrow, R. A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042207 · Cited by 462
Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infections
Odumade, O. A., Hogquist, K. A., & Balfour, H. H. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00044-10 · Cited by 458
Boshoff, C., & Weiss, R. (2002) · Nature Reviews Cancer · doi:10.1038/nrc797 · Cited by 443
Epstein–Barr virus and virus human protein interaction maps
Calderwood, M. A., Venkatesan, K., Xing, L., Chase, M. R., Vazquez, A., Holthaus, A. M., Ewence, A. E., Li, N., Hirozane-Kishikawa, T., Hill, D. E., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702332104 · Cited by 388 · cited 5×
“In latency I, only one protein and some non-coding RNAs are expressed.”
BackgroundInfluentialAn Inquiry into the Mechanisms of Herpes Simplex Virus Latency
Roizman, B., & Sears, A. E. (1987) · Annual Review of Microbiology · doi:10.1146/annurev.mi.41.100187.002551 · Cited by 323
Sawtell, N. M., & Thompson, R. L. (1992) · Journal of Virology · doi:10.1128/jvi.66.4.2150-2156.1992 · Cited by 312
Deshmane, S. L., & Fraser, N. W. (1989) · Journal of Virology · doi:10.1128/jvi.63.2.943-947.1989 · Cited by 309
Chronic herpesvirus reactivation occurs in aging
STOWE, R., KOZLOVA, E., YETMAN, D., WALLING, D., GOODWIN, J., & GLASER, R. (2007) · Experimental Gerontology · doi:10.1016/j.exger.2007.01.005 · Cited by 276
Is immunosenescence infectious?
Pawelec, G., Akbar, A., Caruso, C., Effros, R., Grubeck-Loebenstein, B., & Wikby, A. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.05.006 · Cited by 260
Huff, J. L., & Barry, P. A. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0902.020272 · Cited by 238
Reactivation of Epstein-Barr virus from latency
Amon, W., & Farrell, P. J. (2005) · Reviews in Medical Virology · doi:10.1002/rmv.456 · Cited by 223
Long-term Outcomes of Congenital Cytomegalovirus Infection in Sweden and the United Kingdom
Townsend, C. L., Forsgren, M., Ahlfors, K., Ivarsson, S.-A., Tookey, P. A., & Peckham, C. S. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit018 · Cited by 223
Jochum, S., Moosmann, A., Lang, S., Hammerschmidt, W., & Zeidler, R. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002704 · Cited by 188
Senescence of the Human Immune System
Pawelec, G., Larbi, A., & Derhovanessian, E. (2010) · Journal of Comparative Pathology · doi:10.1016/j.jcpa.2009.09.005 · Cited by 182
Freeman, M. L., Sheridan, B. S., Bonneau, R. H., & Hendricks, R. L. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.322 · Cited by 169
A cultured affair: HSV latency and reactivation in neurons
Wilson, A. C., & Mohr, I. (2012) · Trends in Microbiology · doi:10.1016/j.tim.2012.08.005 · Cited by 167
Klein, E., Kis, L. L., & Klein, G. (2007) · Oncogene · doi:10.1038/sj.onc.1210240 · Cited by 155
Phase I Trial of a CD8+T-Cell Peptide Epitope-Based Vaccine for Infectious Mononucleosis
Elliott, S. L., Suhrbier, A., Miles, J. J., Lawrence, G., Pye, S. J., Le, T. T., Rosenstengel, A., Nguyen, T. H., Allworth, A. M., Burrows, S. R., et al. (2007) · Journal of Virology · doi:10.1128/jvi.01409-07 · Cited by 151
Mocarski, E. S. (2004) · Cellular Microbiology · doi:10.1111/j.1462-5822.2004.00425.x · Cited by 144
Frequent and Recent Human Acquisition of Simian Foamy Viruses Through Apes' Bites in Central Africa
Betsem, E., Rua, R., Tortevoye, P., Froment, A., & Gessain, A. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002306 · Cited by 127
Overview: Cytomegalovirus and the Herpesviruses in Transplantation
Fishman, J. A. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12002 · Cited by 125
Immune responses and latent herpesvirus reactivation in spaceflight.
Stowe, R. P., Mehta, S. K., Ferrando, A. A., Feeback, D. L., & Pierson, D. L. (2001) · PubMed · Cited by 124
Foamy Virus Biology and Its Application for Vector Development
Lindemann, D., & Rethwilm, A. (2011) · Viruses · doi:10.3390/v3050561 · Cited by 114
Longitudinal observation of parechovirus in stool samples from Norwegian infants
Tapia, G., Cinek, O., Witsø, E., Kulich, M., Rasmussen, T., Grinde, B., & Rønningen, K. S. (2008) · Journal of Medical Virology · doi:10.1002/jmv.21283 · Cited by 110
Self-citationControl of viral latency in neurons by axonal mTOR signaling and the 4E-BP translation repressorPreprint
Kobayashi, M., Wilson, A. C., Chao, M. V., & Mohr, I. (2012) · Genes & Development · doi:10.1101/gad.190157.112 · Cited by 97
Periodontal disease in HIV/AIDS
Ryder, M. I., Nittayananta, W., Coogan, M. M., Greenspan, D., & Greenspan, J. S. (2012) · Periodontology 2000 · doi:10.1111/j.1600-0757.2012.00445.x · Cited by 93
Clinical and Molecular Pathogenesis of Varicella Virus Infection
Gilden, D. H., Cohrs, R. J., & Mahalingam, R. (2003) · Viral Immunology · doi:10.1089/088282403322396073 · Cited by 88
CD8+ T cells patrol HSV-1-infected trigeminal ganglia and prevent viral reactivation
Leger, A. J. S., & Hendricks, R. L. (2011) · Journal of NeuroVirology · doi:10.1007/s13365-011-0062-1 · Cited by 82
Patient with severe periodontitis and subgingival Epstein-Barr virus treated with antiviral therapy
Sunde, P. T., Olsen, I., Enersen, M., & Grinde, B. (2008) · Journal of Clinical Virology · doi:10.1016/j.jcv.2008.01.007 · Cited by 82
Self-citationChida, Y., & Mao, X. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.04.009 · Cited by 81
Herpes Simplex Encephalitis: From Virus to Therapy
Rozenberg, F., Deback, C., & Agut, H. (2011) · Infectious Disorders - Drug Targets · doi:10.2174/187152611795768088 · Cited by 80
Sunde, P. T., Olsen, I., Enersen, M., Beiske, K., & Grinde, B. (2008) · Journal of Medical Virology · doi:10.1002/jmv.21180 · Cited by 75
Self-citationReview: Human Gammaherpesvirus Cytokines and Chemokine Receptors
Nicholas, J. (2005) · Journal of Interferon and Cytokine Research · doi:10.1089/jir.2005.25.373 · Cited by 64
Recent advances in vaccine development for herpes simplex virus types I and II
Coleman, J. L., & Shukla, D. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.23289 · Cited by 54
Clearance of influenza virus infections by T cells: risk of collateral damage?
Hillaire, M. L. B., Rimmelzwaan, G. F., & Kreijtz, J. H. C. M. (2013) · Current Opinion in Virology · doi:10.1016/j.coviro.2013.05.002 · Cited by 49
Cinek, O., Witsø, E., Jeansson, S. L., Rasmussen, T., Dřevínek, P., Wetlesen, T., Vavřinec, J., Grinde, B., & Rønningen, K. S. (2005) · Journal of Clinical Virology · doi:10.1016/j.jcv.2005.03.007 · Cited by 44
Self-citationZhong, J., Rist, M., Cooper, L. T., Smith, C., & Khanna, R. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003256 · Cited by 39
Management of herpesvirus infections
Evans, C. M., Kudesia, G., & McKendrick, M. W. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.04.023 · Cited by 34
Functional genomics approaches to understand cytomegalovirus replication, latency and pathogenesis
Landais, I., & Nelson, J. A. (2013) · Current Opinion in Virology · doi:10.1016/j.coviro.2013.06.002 · Cited by 25
Cited by
Epidemiology and Immune Pathogenesis of Viral Sepsis
Lin, G.-L., McGinley, J. P., Drysdale, S. B., & Pollard, A. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02147 · Cited by 351
Applications of gold nanoparticles in virus detection
Draz, M. S., & Shafiee, H. (2018) · Theranostics · doi:10.7150/thno.23856 · Cited by 342
Herpes Virus Reactivation in Astronauts During Spaceflight and Its Application on Earth
Rooney, B. V., Crucian, B. E., Pierson, D. L., Laudenslager, M. L., & Mehta, S. K. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00016 · Cited by 174
The Pathogenesis and Immune Evasive Mechanisms of Equine Herpesvirus Type 1
Laval, K., Poelaert, K. C. K., Van Cleemput, J., Zhao, J., Vandekerckhove, A. P., Gryspeerdt, A. C., Garré, B., van der Meulen, K., Baghi, H. B., Dubale, H. N., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.662686 · Cited by 54
“A hallmark of herpesviruses is the establishment of a reactivable, latent infection in its host (Grinde, 2013).”
BackgroundMechanistic insights into the role of herpes simplex virus 1 in Alzheimer’s disease
Feng, S., Liu, Y., Zhou, Y., Shu, Z., Cheng, Z., Brenner, C., & Feng, P. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1245904 · Cited by 36
Metadata
- Authors
- Grinde, B.
- Venue
- Journal of Oral Microbiology
- Publisher
- Informa UK Limited
- Published
- 2013-01-01
- Volume
- 5
- Issue
- 1
- Pages
- 22766
- ISSN
- 2000-2297 (ISSN-L)
- OpenAlex
- W2034892842
- Cited by
- 489
- References
- 44
- FWCI
- 13.40
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.